Warfarin 2 mg tablet is a generic prescription medicine for oral use, made by 13 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Warfarin
- Brand
- Sold under the generic name
- Strength
- 2 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 1000 tablets, 5000 tablets and 57 more
- Manufacturers
- Sun Pharmaceutical IndustriesIndiaAphena Pharma Solutions - TennesseeBryant Ranch PrepackAmneal PharmaceuticalsA-S Medication SolutionsExelan PharmaceuticalsTeva Pharmaceuticals13 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B01AA03 Warfarin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 July 1999
- Identifiers
- RxCUI 855302, 855332, 855288 +6DailyMed set ID 1244c338-9140-425a-bf2a-9da6b4ac0287, 2cbcc99d-9107-4d39-a1e9-e19305de8b5d, 5256c518-31bf-f73b-e063-6394a90a71da +16NDC 70518-0255, 70518-2381, 67046-1067 +16Application ANDA040616, ANDA202202, ANDA040301 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 13 labelers. The register lists 60 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 51672-4028-1 | Sun Pharmaceutical IndustriesIndia | 15 July 1999 |
| 1000 tablet in 1 bottle | 51672-4028-3 | Sun Pharmaceutical IndustriesIndia | 15 July 1999 |
| 5000 tablet in 1 bottle | 51672-4028-7 | Sun Pharmaceutical IndustriesIndia | 15 July 1999 |
| 100 tablet in 1 bottle | 65162-762-10 | Amneal Pharmaceuticals | 16 August 2010 |
| 1000 tablet in 1 bottle | 65162-762-11 | Amneal Pharmaceuticals | 16 August 2010 |
| 500 tablet in 1 bottle | 65162-762-50 | Amneal Pharmaceuticals | 16 August 2010 |
| 100 tablet in 1 bottle | 76282-328-01 | Exelan Pharmaceuticals | 8 April 2015 |
| 1000 tablet in 1 bottle | 76282-328-10 | Exelan Pharmaceuticals | 8 April 2015 |
| 100 tablet in 1 bottle | 0093-1713-01 | Teva Pharmaceuticals | 14 July 2015 |
| 1000 tablet in 1 bottle | 0093-1713-10 | Teva Pharmaceuticals | 5 May 2015 |
| 30 tablet in 1 bottle | 43353-021-30 | Aphena Pharma Solutions - Tennessee | 25 April 2015 |
| 35 tablet in 1 bottle | 43353-021-35 | Aphena Pharma Solutions - Tennessee | 25 April 2015 |
| 40 tablet in 1 bottle | 43353-021-40 | Aphena Pharma Solutions - Tennessee | 25 April 2015 |
| 45 tablet in 1 bottle | 43353-021-45 | Aphena Pharma Solutions - Tennessee | 25 April 2015 |
| 50 tablet in 1 bottle | 43353-021-50 | Aphena Pharma Solutions - Tennessee | 15 May 2015 |
| 60 tablet in 1 bottle | 43353-021-53 | Aphena Pharma Solutions - Tennessee | 26 April 2015 |
| 75 tablet in 1 bottle | 43353-021-55 | Aphena Pharma Solutions - Tennessee | 22 May 2015 |
| 90 tablet in 1 bottle | 43353-021-60 | Aphena Pharma Solutions - Tennessee | 26 April 2015 |
| 70 tablet in 1 bottle | 43353-021-61 | Aphena Pharma Solutions - Tennessee | 6 August 2015 |
| 120 tablet in 1 bottle | 43353-021-70 | Aphena Pharma Solutions - Tennessee | 22 May 2015 |
| 30 tablet in 1 bottle | 71610-462-30 | Aphena Pharma Solutions - Tennessee | 9 September 2020 |
| 35 tablet in 1 bottle | 71610-462-35 | Aphena Pharma Solutions - Tennessee | 21 December 2020 |
| 40 tablet in 1 bottle | 71610-462-40 | Aphena Pharma Solutions - Tennessee | 21 December 2020 |
| 45 tablet in 1 bottle | 71610-462-45 | Aphena Pharma Solutions - Tennessee | 21 December 2020 |
| 60 tablet in 1 bottle | 71610-462-53 | Aphena Pharma Solutions - Tennessee | 21 December 2020 |
| 90 tablet in 1 bottle | 71610-462-60 | Aphena Pharma Solutions - Tennessee | 21 December 2020 |
| 30 tablet in 1 bottle | 71610-574-30 | Aphena Pharma Solutions - Tennessee | 25 June 2021 |
| 35 tablet in 1 bottle | 71610-574-35 | Aphena Pharma Solutions - Tennessee | 25 June 2021 |
| 40 tablet in 1 bottle | 71610-574-40 | Aphena Pharma Solutions - Tennessee | 25 June 2021 |
| 45 tablet in 1 bottle | 71610-574-45 | Aphena Pharma Solutions - Tennessee | 25 June 2021 |
| 60 tablet in 1 bottle | 71610-574-53 | Aphena Pharma Solutions - Tennessee | 25 June 2021 |
| 90 tablet in 1 bottle | 71610-574-60 | Aphena Pharma Solutions - Tennessee | 25 June 2021 |
| 30 tablet in 1 bottle | 50090-1211-0 | A-S Medication Solutions | 28 November 2014 |
| 30 tablet in 1 bottle | 50090-7464-0 | A-S Medication Solutions | 20 November 2024 |
| 30 tablet in 1 bottle | 71335-0637-1 | Bryant Ranch Prepack | 9 February 2022 |
| 14 tablet in 1 bottle | 71335-0637-2 | Bryant Ranch Prepack | 9 February 2022 |
| 90 tablet in 1 bottle | 71335-0637-3 | Bryant Ranch Prepack | 9 February 2022 |
| 45 tablet in 1 bottle | 71335-0637-4 | Bryant Ranch Prepack | 9 February 2022 |
| 50 tablet in 1 bottle | 71335-0637-5 | Bryant Ranch Prepack | 9 February 2022 |
| 21 tablet in 1 bottle | 71335-0637-6 | Bryant Ranch Prepack | 9 February 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 8 June 1954 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Warfarin 2 mg tablet.
Other strengths and forms of Warfarin
Clinical summary
Warfarin is a vitamin K antagonist indicated for prophylaxis and treatment of venous thrombosis and its extension, pulmonary embolism (PE). It is available as tablets for oral use. MedsAcross supplies Warfarin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about WarfarinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Jantoven prescribing information (Upsher-Smith Laboratories) · U.S. National Library of Medicine, DailyMed
Need Warfarin 2 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.